A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease

Completed · Phase 3

Conditions studied: Dry Eye Disease

In brief

The purpose of this study is to evaluate the effect of AR-15512 ophthalmic solution 0.003% (0.003% AR-15512) on ocular surface characteristics of subjects with dry eye disease (DED).

Key facts

Study ID

NCT06544694

Run by

Alcon Research

People needed

80

Starts

2024-10-08

Expected to finish

2025-03-21

Last updated by the study team

2026-03-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Butchertown Clinical Trials — Louisville, Kentucky, United States
• Oculus Research — Garner, North Carolina, United States
• Wilmington Eye — Leland, North Carolina, United States
• CORE, Inc. — Shelby, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.